{"id":"NCT00438815","sponsor":"Shire","briefTitle":"Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks","officialTitle":"LEVP2006-1 CHANGE 2 Trial (C1-Inhibitor in Hereditary Angioedema Nanofiltration Generation Evaluating Efficacy): Open-Label Safety/Efficacy Repeat Exposure Study of C1INH-nf (Human) in the Treatment of Acute HAE Attacks","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-09-21","primaryCompletion":"2009-03-31","completion":"2009-03-31","firstPosted":"2007-02-22","resultsPosted":"2010-06-09","lastUpdate":"2021-06-08"},"enrollment":113,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hereditary Angioedema"],"interventions":[{"type":"BIOLOGICAL","name":"C1 esterase inhibitor [human] (C1INH-nf)","otherNames":[]}],"arms":[{"label":"Open-label C1INH-nf","type":"EXPERIMENTAL"}],"summary":"The study objective was to evaluate the safety and efficacy of repeat use of C1INH-nf for the treatment of acute HAE attacks.","primaryOutcome":{"measure":"Number of Hereditary Angioedema (HAE) Attacks Treated With C1INH-nf","timeFrame":"Duration of the study (2.5 years)","effectByArm":[{"arm":"Open-label C1INH-nf","deltaMin":609,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":30,"countries":["United States"]},"refs":{"pmids":["23484892","23312695","22856635","22192966","20818886"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":113},"commonTop":["Infusion site pain","Rash"]}}